Development of a Genetic System for Combinatorial Biosynthesis of Lipopeptides in Streptomyces fradiae and Heterologous Expression of the A54145 Biosynthesis Gene Cluster

A54145 factors are calcium-dependent lipopeptide antibiotics produced by Streptomyces fradiae NRRL 18160. A54145 is structurally related to the clinically important daptomycin, and as such may be a useful scaffold for the development of a novel lipopeptide antibiotic. We developed methods to genetically manipulate S. fradiae by deletion mutagenesis and conjugal transfer of plasmids from Escherichia coli. Cloning the complete pathway on a bacterial artificial chromosome (BAC) vector and the construction of ectopic trans-complementation with plasmids utilizing the φC31 or φBT1 site-specific integration system allowed manipulation of A54145 biosynthesis. The BAC clone pDA2002 was shown to harbor the complete A54145 biosynthesis gene cluster by heterologous expression in Streptomyces ambofaciens and Streptomyces roseosporus strains in yields of >100 mg/liter. S. fradiae mutants defective in LptI methyltransferase function were constructed, and they produced only A54145 factors containing glutamic acid (Glu₁₂), at the expense of factors containing 3-methyl-glutamic acid (3mGlu₁₂). This provided a practical route to produce high levels of pure Glu₁₂-containing lipopeptides. A suite of mutant strains and plasmids was created for combinatorial biosynthesis efforts focused on modifying the A54145 peptide backbone to generate a compound with daptomycin antibacterial activity and activity in Streptococcus pneumoniae pulmonary infections.The calcium-dependent cyclic acidic lipodepsipeptide antibiotics were first reported in the 1980s and 1990s (8). These include A21978C, produced by Streptomyces roseosporus (17, 18), calcium-dependent antibiotic (CDA), produced by Streptomyces coelicolor (26), and A54145, produced by Streptomyces fradiae NRRL 18160 (11, 12, 23). A21978C (Fig. ​(Fig.1)1) has been of particular interest because the N-decanoyl lipid tail derivative of the A21978C peptide is daptomycin (8), which is approved for the treatment of complicated skin and skin structure infections caused by Gram-positive bacteria (2) and for bacteremia and right-sided endocarditis caused by Staphylococcus aureus, including strains resistant to methicillin (MRSA) (21). Daptomycin lacks efficacy in community-acquired pneumonia (CAP) infections, even though it is very active in vitro against the predominant pathogen, Streptococcus pneumoniae (8, 43). In vitro studies have shown that daptomycin becomes sequestered in bovine pulmonary surfactant, most likely in the lipid component, and has decreased antibacterial potency against Gram-positive pathogens (46); this may be a significant factor contributing to the poor clinical efficacy in CAP. Attempts to improve the efficacy of daptomycin through chemical modifications of the lipid side chain or additions to the δ-amino group of ornithine (Orn₆) (reviewed in reference 8), or by molecular engineering of peptide assembly (4, 13, 25, 37-39), have not generated a lead molecule with sufficient in vivo efficacy in a mouse pneumonia model for S. pneumoniae.Open in a separate windowFIG. 1.Structures of the lipopeptide antibiotics and NRPS protein subunit relationships. (Top) A54145 factors normally produced by S. fradiae. Note that factors A, A₁, D, and F have Glu at position 12, and factors B, B₁, C, and E have 3mGlu at position 12. (Bottom) A21978C factors normally produced by S. rosesosporus and daptomycin.A54145 factors share a number of features in common with daptomycin, but they differ at several amino acid positions (Fig. ​(Fig.1).1). The most biologically active A54145 factors against S. aureus contain four modified amino acids, l-hydroxy-Asn₂ (hAsn₂), sarcosine₅ (Sar₅), l-methoxy-Asp₉ (mOAsp₉), and l-3-methyl-Glu₁₂ (3mGlu₁₂) (14). During a standard fermentation, multiple A54145 factors are produced as the result of natural variation at position 12 (3mGlu or Glu), at position 13 (Ile or Val) and at the lipid tail attached to the peptide core. The A54145 factors A, A₁, and D (collectively designated the A-core) have the identical peptide containing Glu₁₂ and Ile₁₃ but have different lipid tails, whereas factors B, B₁, and E (the B-core) contain 3mGlu₁₂ and Ile₁₃. During fermentation of S. fradiae, factor A accumulates as a major component but plateaus early, and factor B₁ accumulates preferentially late in the fermentation (11, 12). In studies at Eli Lilly and Company, it was shown that the B-core factors were slightly more potent antibiotics, but factor B was substantially more toxic than its Glu₁₂-containing counterpart, factor A₁ (14).During the development of molecular engineering approaches to modify daptomycin biosynthesis, the genes for A54145 lipopeptide biosynthesis (lpt) were cloned and sequenced to provide nonribosomal peptide synthetase (NRPS) modules and subunits to exchange with those of daptomycin (37). Since some of the A54145 A-core factors were shown to be much less inhibited by bovine surfactant than daptomycin (40), the A54145 A-core lipopeptides should be useful starting points for both chemical and molecular engineering modification studies. We initiated a program to develop molecular genetics methods, with plasmids and host cloning strains to facilitate molecular engineering of A54145 biosynthesis in S. fradiae.In this report, we describe the engineering of a bacterial artificial chromosome (BAC) containing the A54145 biosynthesis genes by using λ-Red-mediated recombination in Escherichia coli and expression of the A54145 biosynthesis pathway in heterologous streptomycetes. The development of S. fradiae strains deleted for multiple A54145 genes and the construction of plasmid vectors with conjugation and site-specific integration functions for ectopic expression of sets of A54145 biosynthesis genes in S. fradiae and combinatorial biosynthesis (40) are discussed. This genetic system was used to generate a strain with deletion of lptI, a gene that encodes a methyltransferase involved in the biosynthesis of 3mGlu₁₂, and the mutant produced the desired A-core lipopeptides containing Glu₁₂, which are important starting materials for medicinal chemistry approaches to produce novel lipopeptides.     

Cloning and Heterologous Expression of the Thioviridamide Biosynthesis Gene Cluster from Streptomyces olivoviridis

Thioviridamide is a unique peptide antibiotic containing five thioamide bonds from Streptomyces olivoviridis. Draft genome sequencing revealed a gene (the tvaA gene) encoding the thioviridamide precursor peptide. The thioviridamide biosynthesis gene cluster was identified by heterologous production of thioviridamide in Streptomyces lividans.     

Identification and Heterologous Expression of the Chaxamycin Biosynthesis Gene Cluster from Streptomyces leeuwenhoekii

Streptomyces leeuwenhoekii, isolated from the hyperarid Atacama Desert, produces the new ansamycin-like compounds chaxamycins A to D, which possess potent antibacterial activity and moderate antiproliferative activity. We report the development of genetic tools to manipulate S. leeuwenhoekii and the identification and partial characterization of the 80.2-kb chaxamycin biosynthesis gene cluster, which was achieved by both mutational analysis in the natural producer and heterologous expression in Streptomyces coelicolor A3(2) strain M1152. Restoration of chaxamycin production in a nonproducing ΔcxmK mutant (cxmK encodes 3-amino-5-hydroxybenzoic acid [AHBA] synthase) was achieved by supplementing the growth medium with AHBA, suggesting that mutasynthesis may be a viable approach for the generation of novel chaxamycin derivatives.     

The Gene Cluster for Spectinomycin Biosynthesis and the Aminoglycoside-Resistance Function of spcM in Streptomyces spectabilis

The gene cluster for spectinomycin biosynthesis from Streptomyces spectabilis was analyzed completely and registered under the accession number EU255259 at the National Center for Biotechnology Information. Based on sequence analysis, spcM of the S. spectabilis cluster is the only methyltransferase candidate required for methylation in spectinomycin biosynthesis. It has high similarity with the conserved domain of DNA methylase, which contains both N-4 cytosine-specific DNA methylases and N-6 adenine-specific DNA methylases. Nucleotide methylation can provide antibiotic resistance, such as 16S rRNA methyltransferase, to Enterobacteriaceae. We therefore tested a hypothesis that SpcM offers aminoglycoside resistance to bacteria. The heterologous expression of spcM in Escherichia coli and S. lividans enhanced resistance against spectinomycin and its relative aminoglycoside antibiotics. We therefore propose that one of the functions of SpcM may be conferring aminoglycoside antibiotic resistance to cells.     

Cloning and Characterization of a Gene Cluster for Hatomarubigin Biosynthesis in Streptomyces sp. Strain 2238-SVT4

Streptomyces sp. strain 2238-SVT4 produces hatomarubigins A, B, C, and D, which belong to the angucycline family. Among them, hatomarubigin D has a unique dimeric structure with a methylene linkage. PCR using aromatase and cyclase gene-specific primers identified the hrb gene cluster for angucycline biosynthesis in Streptomyces sp. 2238-SVT4. The cluster consisted of 30 open reading frames, including those for the minimal polyketide synthase, ketoreductase, aromatase, cyclase, O-methyltransferase, oxidoreductase, and oxygenase genes. Expression of a part of the gene cluster containing hrbR1 to hrbX in Streptomyces lividans TK23 resulted in the production of hatomarubigins A, B, and C. Hatomarubigin D was obtained from the conversion of hatomarubigin C by a purified enzyme encoded by hrbY, among the remaining genes.The angucycline antibiotics are a large group of naturally occurring aromatic polyketides of microbial origin (11, 15). They exhibit a wide range of biological activities, which include antibacterial, antiviral, antitumor, enzyme inhibitory, and platelet aggregation inhibitory effects. Although all the members contain a benz[a]anthraquinone skeleton of decaketide origin, their structural diversity is very broad and they have a wide variety of oxidation states. Hatomarubigins A, B, C, and D (Fig. ​(Fig.1)1) belong to the angucycline family and reverse colchicine resistance in multidrug-resistant tumor cells (8). Among them, hatomarubigin D is a unique hatomarubigin C dimer with a methylene linkage. Such a dimer has not been reported previously, and little is known about the mechanism of the methylene bridge formation between two aromatic rings. In this study, a gene cluster for hatomarubigin biosynthesis was identified in Streptomyces sp. strain 2238-SVT4, and a part of the gene cluster was expressed in Streptomyces lividans to produce the hatomarubigins.Open in a separate windowFIG. 1.Structures of angucycline antibiotics.     

Candicidin Biosynthesis Gene Cluster Is Widely Distributed among Streptomyces spp. Isolated from the Sediments and the Neuston Layer of the Trondheim Fjord,Norway

A large number of Streptomyces bacteria with antifungal activity isolated from samples collected in the Trondheim fjord (Norway) were found to produce polyene compounds. Investigation of polyene-containing extracts revealed that most of the isolates produced the same compound, which had an atomic mass and UV spectrum corresponding to those of candicidin D. The morphological diversity of these isolates prompted us to speculate about the involvement of a mobile genetic element in dissemination of the candicidin biosynthesis gene cluster (can). Eight candicidin-producing isolates were analyzed by performing a 16S rRNA gene-based taxonomic analysis, pulsed-field gel electrophoresis, PCR, and Southern blot hybridization with can-specific probes. These analyses revealed that most of the isolates were related, although they were morphologically diverse, and that all of them contained can genes. The majority of the isolates studied contained large plasmids, and two can-specific probes hybridized to a 250-kb plasmid in one isolate. Incubation of the latter isolate at a high temperature resulted in loss of the can genes and candicidin production, while mating of the “cured” strain with a plasmid-containing donor restored candicidin production. The latter result suggested that the 250-kb plasmid contains the complete can gene cluster and could be responsible for conjugative transfer of this cluster to other streptomycetes.Actinomycete bacteria, especially those belonging to the family Streptomycetaceae, are well-known producers of secondary metabolites with diverse biological activities. Representatives of the genus Streptomyces produce a variety of antibiotics with antibacterial, antifungal, and antitumor activities. The majority of antibiotic-producing streptomycetes have been isolated from terrestrial environments, while antibiotic-producing streptomycetes from the marine sources remain largely unexplored. Therefore, studies of streptomycetes from the marine environment are important for unraveling their potential for antibiotic production. In addition, such studies might reveal the means by which antibiotic biosynthesis and resistance genes are spread in nature.It is widely acknowledged that plasmids play an important role in genetic exchange between bacterial species. Conjugative plasmids are quite common in Streptomyces strains (13), and a number of these mobile genetic elements have been characterized in detail. The characterized mobile genetic elements include both circular plasmids, such as pIJ101 from Streptomyces lividans (14) and SCP2 from Streptomyces coelicolor (2, 35), and linear plasmids, such as SLP2 from S. lividans (6) and SCP1 from S. coelicolor (38, 39). The presence of a linear plasmid in Streptomyces was first reported in 1979, and the plasmid was the 17-kb pSLA2 plasmid of Streptomyces rochei (11). SCP1 of S. coelicolor was discovered in the early 1970s (38, 39), but because of its large size (356 kb), isolation of this plasmid with conventional techniques was not possible and therefore it was not recognized as a linear plasmid until pulsed-field gel electrophoresis (PFGE) was invented. Later, SCP1 was shown to harbor a complete set of genes for biosynthesis of the antibiotic methylenomycin (21; K. F. Chater, C. J. Bruton, S. J. O''Rouke, and A. W. Wietzorrek, 5 July 2001, Patent Cooperation Treaty international application WO/2001/048228), while another linear plasmid, found in S. rochei, has been shown to contain genes for biosynthesis of both lankamycin and lankacidin (16, 19, 28, 36). Other examples of plasmids include pPZG103 carrying oxytetracycline biosynthesis genes acquired from the chromosome of Streptomyces rimosus (10) and pKSL from Streptomyces lasaliensis, which might be involved in the production of lasalocid and/or echinomycin (17, 20).Linear plasmids can be transferred between Streptomyces strains by means of conjugation, and SCP1 is an example of a conjugative linear plasmid as it is easily transferred from an SCP1⁺ strain to an SCP1⁻ strain (39). Interspecific transfer to S. lividans and Streptomyces parvulus has also been reported for this plasmid, and it was demonstrated that the recipient strains had acquired the ability to produce and be resistant to methylenomycin (12, 21). Transfer of intact linear plasmids containing mercury resistance genes from two Streptomyces strains isolated from the marine environment to S. lividans, conferring mercury resistance to the initially mercury-sensitive recipient, has been reported by Ravel et al. (32). It has also been shown that interspecific transfer of linear plasmids is possible in sterile amended soil microcosms, suggesting that mercury resistance might be spread by plasmid transfer in polluted environments (31).We report here isolation and screening of several thousand actinobacterial strains from the Trondheim fjord (Norway), which resulted in identification of producers of both known and potentially new polyene macrolides with antifungal activity. The ability to produce the polyene macrolide candicidin D was found to be widespread among the Trondheim fjord Streptomyces isolates. We also report that the candicidin biosynthesis genes (can) are present on a linear plasmid identified in one of these isolates, suggesting that the can genes might be spread by means of conjugation.     

链霉菌Streptomyces tenebrarius H6中与抗生素有关的糖生物合成基因的克隆

链霉菌S.tenebrarius H6产生多种氨基糖甙类抗生素,主要有阿普霉素、妥普霉素及卡那霉素B,其中阿普霉素因含有8碳糖的一种特殊结构令人注目,它的抗菌谱广,特别是对革兰氏阴性菌有较强的抗菌活性,不容易产生耐药性,对已有的耐药菌产生的氨基糖苷转移酶等失活酶仍有抵抗力.主要用于牛、猪、鸡等的大肠杆菌、沙门氏菌和支原体所引起的白痢、腹泻和肺炎等疾病.迄今有关八碳糖生物合成基因簇的研究在国内外尚无报道,在该菌株开展有关糖合成代谢基因的研究有着一定的意义.     

Biosynthesis of Cobalamine,Erythromycin and Chlortetracycline by Streptomyces Species

Attempts were devoted to use Streptomyces aureofaciens and Streptomyces erythreus, the antibiotics producers as sources for the biosynthesis of cobalamine. The constituents of the fermentation medium and the strain play an important role in the biosynthesis of vitamin B₁₂. The same strain produced different amounts of antibiotic and vitamin on the two different constitutive media. The increase of the phosphorus concentration in the fermentation medium—within limits—increased the vitamin B₁₂ biosynthesis. The optimal concentration of phosphorus favourable for the synthesis of cobalamine was inhibitive for the antibiotic production. The phosphorus level in the fermentation medium plays an important role in the metabolism of carbohydrate and consequently on the biosynthesis of antibiotics. Low concentration of 5,6-dimethylbenzimidazole (cobalamine precursor) in the presence of suitable phosphorus induced the microorganism to increase its biosynthetic potentiality for the vitamin B₁₂ production.     

罗中链霉菌中衣霉素基因簇的克隆及异源表达

衣霉素属于核苷类抗生素,具有抑制蛋白质N-糖基化的活性,是潜在的药物先导化合物.罗中链霉菌(Streptomyces luozzhongensis)TRM49605是一株产衣霉素的链霉菌属(Streptomyces)的新物种.本研究旨在探索TRM49605中衣霉素生物合成基因簇的生物学功能,为新型药物开发提供理论依据....     

Gene Cluster Involved in the Biosynthesis of Griseobactin,a Catechol-Peptide Siderophore of Streptomyces sp. ATCC 700974

The main siderophores produced by streptomycetes are desferrioxamines. Here we show that Streptomyces sp. ATCC 700974 and several Streptomyces griseus strains, in addition, synthesize a hitherto unknown siderophore with a catechol-peptide structure, named griseobactin. The production is repressed by iron. We sequenced a 26-kb DNA region comprising a siderophore biosynthetic gene cluster encoding proteins similar to DhbABCEFG, which are involved in the biosynthesis of 2,3-dihydroxybenzoate (DHBA) and in the incorporation of DHBA into siderophores via a nonribosomal peptide synthetase. Adjacent to the biosynthesis genes are genes that encode proteins for the secretion, uptake, and degradation of siderophores. To correlate the gene cluster with griseobactin synthesis, the dhb genes in ATCC 700974 were disrupted. The resulting mutants no longer synthesized DHBA and griseobactin; production of both was restored by complementation with the dhb genes. Heterologous expression of the dhb genes or of the entire griseobactin biosynthesis gene cluster in the catechol-negative strain Streptomyces lividans TK23 resulted in the synthesis and secretion of DHBA or griseobactin, respectively, suggesting that these genes are sufficient for DHBA and griseobactin biosynthesis. Griseobactin was purified and characterized; its structure is consistent with a cyclic and, to a lesser extent, linear form of the trimeric ester of 2,3-dihydroxybenzoyl-arginyl-threonine complexed with aluminum under iron-limiting conditions. This is the first report identifying the gene cluster for the biosynthesis of DHBA and a catechol siderophore in Streptomyces.Iron is an essential element for the growth and proliferation of nearly all microorganisms. In the presence of oxygen, the soluble ferrous iron is readily oxidized to its ferric form, which exists predominantly as a highly insoluble hydroxide complex at neutral pH. To overcome iron limitation, many bacteria synthesize and secrete low-molecular-weight, high-affinity ferric iron chelators, called siderophores (38, 53). Following the chelation of Fe³⁺ in the medium, the iron-siderophore complex is actively taken up by its cognate ABC transport system, and Fe³⁺ is subsequently released by reduction to Fe²⁺ and/or by hydrolysis of the siderophore (28, 32, 36). The three main classes of siderophores contain catecholates, hydroxamates, or (α-hydroxy-)carboxylates as iron-coordinating ligands, but mixed siderophores and siderophores containing other functional groups, such as diphenolates, imidazoles, and thiazolines, have also been found (16, 38).Siderophores containing peptide moieties are synthesized by proteins belonging to the nonribosomal peptide synthetase (NRPS) family (16, 38). These multimodular enzymes function as enzymatic assembly lines in which the order of the modules usually determines the order of the amino acids incorporated into the peptide (19, 34). Each module contains the complete information for an elongation step combining the catalytic functions for the activation of the amino acid by the adenylation (A) domain, the tethering of the corresponding adenylate to the terminal thiol of the enzyme-bound 4′-phosphopantetheinyl (4′-PP) cofactor by the peptidyl carrier protein (PCP) domain, and the formation of the peptide bond by the condensation (C) domain (26, 34, 52). At the end, the product is released by the C-terminal thioesterase (TE) domain by hydrolysis or by cyclization via intramolecular condensation. Each adenylation domain recognizes a specific amino acid, and its substrate specificity can be predicted by its sequence. An NRPS specificity-conferring code consisting of 10 nonadjacent amino acid residues in the A domain has been proposed (49). Exceptions to the “colinearity-rule” (19) have been discovered. For example, in the biosynthesis of the siderophores enterobactin and bacillibactin, all the modules in the NRPS are used iteratively, and the TE domain stitches the chains together into a cyclic product (35, 45). Enterobactin is the trilactone of 2,3-dihydroxybenzoyl-serine, and bacillibactin is the lactone of 2,3-dihydroxybenzoyl-glycyl-threonine.The typical siderophores produced by streptomycetes are desferrioxamines (24), and the genes encoding the enzymes for their biosynthesis have been identified (5). Recently, structurally different siderophores have been reported to be coproduced with desferrioxamines in some species, e.g., coelichelin in Streptomyces coelicolor (9, 30) and enterobactin in Streptomyces tendae (18). The genes encoding the proteins for the biosynthesis of enterobactin in S. tendae remain unknown.Here we describe the gene cluster for the biosynthesis of a new siderophore, named griseobactin, produced by Streptomyces sp. strain ATCC 700974 and some strains of Streptomyces griseus. By sequencing two cosmids isolated from a Streptomyces sp. strain ATCC 700974 genomic library, we assigned the encoded proteins to enzymes that convert chorismate to 2,3-dihydroxybenzoate (DHBA), and to proteins involved in nonribosomal peptide biosynthesis and in the export, uptake, and utilization of siderophores. Knockout mutagenesis and heterologous expression confirmed the requirement of this gene cluster for the biosynthesis of griseobactin. This is the first report on the identification of the genes responsible for DHBA and catechol siderophore biosynthesis in Streptomyces.     

Intergeneric Conjugation in Streptomyces peucetius and Streptomyces sp. Strain C5: Chromosomal Integration and Expression of Recombinant Plasmids Carrying the chiC Gene

Intergeneric conjugal transfer of plasmid DNA from Escherichia coli to Streptomyces circumvents problems such as host-controlled restriction and instability of foreign DNA during the transformation of Streptomyces protoplasts. The anthracycline antibiotic-producing strains Streptomyces peucetius and Streptomyces sp. strain C5 were transformed using E. coli ET12567(pUZ8002) as a conjugal donor. When this donor species, carrying pSET152, was mated with Streptomyces strains, the resident plasmid was mobilized to the recipient and the transferred DNA was also integrated into the recipient chromosome. Analysis of the exconjugants showed stable integration of the plasmid at a single chromosomal site (attB) of the Streptomyces genome. The DNA sequence of the chromosomal integration site was determined and shown to be conserved. However, the core sequence, where the crossover presumably occurred in C5 and S. peucetius, is TTC. These results also showed that the C31 integrative recombination is active and the phage attP site is functional in S. peucetius as well as in C5. The efficiency and specificity of C31-mediated site-specific integration of the plasmid in the presence of a 3.7-kb homologous DNA sequence indicates that integrative recombination is preferred under these conditions. The integration of plasmid DNA did not affect antibiotic biosynthesis or biosynthesis of essential amino acids. Integration of a single copy of a mutant chiC into the wild-type S. peucetius chromosome led to the production of 30-fold more chitinase.     

Characterization of the Gene Cluster Responsible for Cylindrospermopsin Biosynthesis

Toxic cyanobacterial blooms cause economic losses and pose significant public health threats on a global scale. Characterization of the gene cluster for the biosynthesis of the cyanobacterial toxin cylindrospermopsin (cyr) in Cylindrospermopsis raciborskii AWT205 is described, and the complete biosynthetic pathway is proposed. The cyr gene cluster spans 43 kb and is comprised of 15 open reading frames containing genes required for the biosynthesis, regulation, and export of the toxin. Biosynthesis is initiated via an amidinotransfer onto glycine followed by five polyketide extensions and subsequent reductions, and rings are formed via Michael additions in a stepwise manner. The uracil ring is formed by a novel pyrimidine biosynthesis mechanism and tailoring reactions, including sulfation and hydroxylation that complete biosynthesis. These findings enable the design of toxic strain-specific probes and allow the future study of the regulation and biological role of cylindrospermopsin.     

A Systematic Computational Analysis of Biosynthetic Gene Cluster Evolution: Lessons for Engineering Biosynthesis

Bacterial secondary metabolites are widely used as antibiotics, anticancer drugs, insecticides and food additives. Attempts to engineer their biosynthetic gene clusters (BGCs) to produce unnatural metabolites with improved properties are often frustrated by the unpredictability and complexity of the enzymes that synthesize these molecules, suggesting that genetic changes within BGCs are limited by specific constraints. Here, by performing a systematic computational analysis of BGC evolution, we derive evidence for three findings that shed light on the ways in which, despite these constraints, nature successfully invents new molecules: 1) BGCs for complex molecules often evolve through the successive merger of smaller sub-clusters, which function as independent evolutionary entities. 2) An important subset of polyketide synthases and nonribosomal peptide synthetases evolve by concerted evolution, which generates sets of sequence-homogenized domains that may hold promise for engineering efforts since they exhibit a high degree of functional interoperability, 3) Individual BGC families evolve in distinct ways, suggesting that design strategies should take into account family-specific functional constraints. These findings suggest novel strategies for using synthetic biology to rationally engineer biosynthetic pathways.     

Analysis of the Mycosamine Biosynthesis and Attachment Genes in the Nystatin Biosynthetic Gene Cluster of Streptomyces noursei ATCC 11455

The polyene macrolide antibiotic nystatin produced by Streptomyces noursei contains a deoxyaminosugar mycosamine moiety attached to the C-19 carbon of the macrolactone ring through the β-glycosidic bond. The nystatin biosynthetic gene cluster contains three genes, nysDI, nysDII, and nysDIII, encoding enzymes with presumed roles in mycosamine biosynthesis and attachment as glycosyltransferase, aminotransferase, and GDP-mannose dehydratase, respectively. In the present study, the functions of these three genes were analyzed. The recombinant NysDIII protein was expressed in Escherichia coli and purified, and its in vitro GDP-mannose dehydratase activity was demonstrated. The nysDI and nysDII genes were inactivated individually in S. noursei, and analyses of the resulting mutants showed that both genes produced nystatinolide and 10-deoxynystatinolide as major products. Expression of the nysDI and nysDII genes in trans in the respective mutants partially restored nystatin biosynthesis in both cases, supporting the predicted roles of these two genes in mycosamine biosynthesis and attachment. Both antifungal and hemolytic activities of the purified nystatinolides were shown to be strongly reduced compared to those of nystatin, confirming the importance of the mycosamine moiety for the biological activity of nystatin.     

类胡萝卜素合成的相关基因及其基因工程

类胡萝卜素具有多种生物功能,尤其在保护人类健康方面起着重要的作用,如它们是合成维生素A的前体,能够增强人体免疫力和具有防癌抗癌的功效。人体自身不能合成类胡萝卜素,必须通过外界摄入;但类胡萝卜素在许多植物中含量较低,并且很难用化学方法合成。随着类胡萝卜素生物合成途径的阐明及其相关基因的克隆,运用基因工程手段调控类胡萝卜素的生物合成已成为可能。本文综述了微生物和高等植物类胡萝卜素生物合成途径中相关基因的克隆,以及运用这些基因通过异源微生物生产类胡萝卜素和提高作物类胡萝卜素含量的基因工程研究进展。     

细菌胞外多糖的生物合成与基因控制

细菌胞外多糖是指细菌在生长发育过程中合成并分泌到细胞外的长链,高分子糖类聚合物。细菌胞外多糖的生物合成途径涉及装配、多聚化及运输三个过程,是多种酶和转运系统的结果,其发生的部位包括胞内和胞外,有些合成过程会发生在细胞壁上,对于胞外多糖合成相关基因的报道,发现控制胞外多糖合成是一大类基因簇,不同的菌株其基因簇的数量和种类各不相同。这些研究的不断更新为将来胞外多糖的应用提供了更加广阔的前景。     

变构菌素生物合成基因簇的研究进展

变构菌素是从Streptomyces griseochromogenes菌株中分离得到的第一个高选择性的蛋白磷酸化酶-1（PP-1）抑制剂。变构菌素及其衍生物在神经系统紊乱、代谢综合症、呼吸系统及相关疾病、免疫抑制、肿瘤治疗等诸多领域都有着广泛的应用前景,因而引起了人们对其生物合成途径的研究兴趣。介绍了近年来变构菌素生物合成途径的研究进展。